Abstract
The true infection rate of COVID-19 and the infection fatality rate in the whole population have been estimated for each country based on the open data. The estimate well coincided with local surveys. The fact that several to hundred times of identified cases are already infected might require reconsideration of the strategy to cope with COVID-19. Attenuation of the viral virulence may be considered to be a goal, especially in countries with already low fatality rate, mainly Asian countries.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding reported
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics committee of the Teikyo University judged that no approval is necessary for this study utilizing only open data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Prof. Masahiro Sonoo, the corresponding author has the availability of all data referred to in the manuscript.
